Elevated levels of CEA in biological samples (e.g. serum) are related to colorectal, pancreatic, liver, lung, breast, and ovarian cancer.6,7 Therefore, the identification of the concentration of cancer biomarkers in serum is one of the most promising strategies for early and effective cancer diagnosis. This evidence concerns the gene CEACAM5 and cancer.